MPHMedicureMPH info
$0.74info9.78%24h
Global rank33493
Market cap$7.60M
Change 7d-0.98%
YTD Performance-25.19%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Medicure (MPH) Stock Overview

    Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

    MPH Stock Information

    Symbol
    MPH
    Address
    2-1250 Waverley StreetWinnipeg, MB R3T 6C6Canada
    Founded
    -
    Trading hours
    -
    Website
    https://www.medicure.com
    Country
    🇨🇦 Canada
    Phone Number
    204 487 7412

    Medicure (MPH) Price Chart

    -
    Value:-

    Medicure Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.7418561092952367
    N/A
    Market Cap
    $7.60M
    N/A
    Shares Outstanding
    10.25M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org